News – Page 358 – Endpoints News

Avenue touts progress with FDA on embattled pain candidate after two CRLs, failed adcomm

3 years ago

Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?

3 years ago

Cancers caused by HPV are still on the rise, even as awareness of the connection is dropping: #AACR23

3 years ago

#trekfortomorrow: Early lessons from the trail

3 years ago

GSK will buy Bellus Health for $2B, setting up showdown with Merck

3 years ago

Danaher's takeover interest of Catalent may be on the back burner: report

3 years ago

Adcomm unanimously recommends Entasis' bacterial pneumonia candidate for resistant infections

3 years ago

PhRMA calls document destruction part of new guidance on drug price negotiations 'unconstitutional'

3 years ago

FDA inspection at Lupin manufacturing site uncovers breakdowns left uninvestigated and data questions

3 years ago

Kinnate Biopharma touts early efficacy in pan-RAF program: #AACR23

3 years ago

Eli Lilly invests another $1.6B into Indiana manufacturing sites

3 years ago

Gamida Cell wins FDA approval for new cord blood-based therapy for cancer patients

3 years ago

Abortion pill can't just 'snap back' to pre-2016, FDA's Woodcock tells SCOTUS

3 years ago

Apellis raises uncommon eye disease profile with ‘The Fonz’ actor Henry Winkler

3 years ago

Vaxcyte unveils new data on challenger to Pfizer’s Prevnar, heads toward PhIII

3 years ago

Regeneron chairman Roy Vagelos will retire, and Len Schleifer and George Yancopoulos will co-lead the board

3 years ago

Smart Immune picks up $5M from Gates Foundation; Oxford Nanopore teams up with French diagnostics player

3 years ago

Regeneron reveals data behind deprioritized BCMA/CD3 bispecific: #AACR23

3 years ago

J&J’s Janssen taps into Pipeline Therapeutics’ neuroscience asset for $50M upfront

3 years ago

Moderna debuts corporate ad campaign 'telling the story of mRNA’ across its ambitions

3 years ago

Japanese CRO buys back penny stock spinout while awaiting FDA decision on migraine candidate

3 years ago

GSK stopped two UTI antibiotic trials early after meeting efficacy endpoints. Now it’s sharing the full data

3 years ago

Exclusive: Genmab's CEO touts M&A potential as it inks first partnership outside cancer

3 years ago

VCs 'Complement' European biotech with $79M for retinal AAV gene therapy trial next year

3 years ago

First page Previous page 355 356 357358359 360 361 Next page Last page